Catalyst Pharmaceuticals Files 8-K
Ticker: CPRX · Form: 8-K · Filed: May 7, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
TL;DR
Catalyst Pharma filed a routine 8-K on 5/7/25. No major news yet.
AI Summary
Catalyst Pharmaceuticals, Inc. filed an 8-K on May 7, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific details on new events or financial figures within the provided text, but indicates a standard reporting update.
Why It Matters
This filing serves as a standard disclosure for Catalyst Pharmaceuticals, Inc., informing stakeholders about significant events or financial updates as required by the SEC.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain information that inherently increases risk.
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Filer
- May 7, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 33134 (zip_code) — Business Address Zip Code
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as item information, but the provided text does not detail the specific nature of these events or statements.
When was this 8-K report filed?
The report was filed on May 7, 2025.
What is the principal executive office address for Catalyst Pharmaceuticals, Inc.?
The principal executive offices are located at 355 Alhambra Circle, Suite 801, Coral Gables, Florida, 33134.
What is Catalyst Pharmaceuticals, Inc.'s fiscal year end?
The company's fiscal year ends on December 31st (1231).
Has Catalyst Pharmaceuticals, Inc. had previous names?
Yes, the company was formerly known as CATALYST PHARMACEUTICAL PARTNERS, INC. (name change on 20110215) and Catalyst Pharmaceutical Partners, Inc. (name change on 20060719).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).